Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebivolol vs Metoprolol ER and HCTZ in Hypertensive Patients with Type 2 Diabetes
NCT00744237Phase 4Completed
- Sponsor
- Forest Laboratories
- Start
- Aug 2008
- Primary completion
- Jul 2010
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 4, randomised, double-blind trial of nebivolol in hypertension (HTN) (3 arms), sponsored by Forest Laboratories. Primary endpoint: Glycosylated Hemoglobin at 26 weeks. Started Aug 2008; status: completed.
02
Drugs
nebivolol
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT00744237.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00744237.